Volume 25, 2021 Archive

Six issues from 2021 in one convenient archive.

This archive contains the following articles listed by volume, issue and page number:

Issue/Volume	Title
Issues Included
January/February 2021 Vol. 25 No. 1	Volume 25, Number 1
March/April 2021 Vol. 25 No. 2	Volume 25, Number 2
May/June 2021 Vol. 25 No. 3	Volume 25, Number 3
July/August 2021 Vol. 25 No. 4	Volume 25, Number 4
September/October 2021 Vol. 25 No. 5	Volume 25, Number 5
November/December 2021 Vol. 25 No. 6	Volume 25, Number 6

Volume 25, 2021 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2021 Pg. 4	PreScription: The NASEM cBHT Report, Part 2 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 6-12	Cleanroom Cleanliness Author(s): Mulder Kyle
Jan/Feb 2021 Pg. 14-17	Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 Author(s): DeRosa Angela
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2021 Pg. 24-28	Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Author(s): McElhiney Linda F
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 40	Calculations Author(s): Stockton Shelly J
Jan/Feb 2021 Pg. 42	Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 43	Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 44	Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 45	Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 48-51	Design and Performance of an Inexpensive Water Activity Meter Author(s): Gilda Sagar S, Schober Joseph M, McPherson Timothy
Jan/Feb 2021 Pg. 52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021 Pg. 62-72	Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma Author(s): Teeranachaideekul Veerawat, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn
Jan/Feb 2021 Pg. 73-81	Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design Author(s): Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Mar/Apr 2021 Pg. 92	PreScription: The Past (-->2020), The Present, and The Future (2021-->) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Mar/Apr 2021 Pg. 100-103	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing Author(s): Riepl Mike
Mar/Apr 2021 Pg. 104-108	Experimental Multidisciplinary Approach Based on Compounded Capsule's Quality Evaluation for Pharmacy Undergraduate Courses Author(s): dos Santos Matheus Skrcek Ribeiro, de Lima Amanda Muniz dos Santos, Christoff Adriana de Oliveira, Teixeira Mariana Lopes, Carneiro Jaqueline
Mar/Apr 2021 Pg. 109-113	Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Author(s): Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021 Pg. 115-124	Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Author(s): Kelley Brian
Mar/Apr 2021 Pg. 126-128	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 140-141	Calculations Author(s): Stockton Shelly J, Bui Phi H
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 143	Canine Soft Chew Base (Veterinary) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Mar/Apr 2021 Pg. 156-162	Stability of Fagron's Phytobase Cream Compounded with Various Hormones Author(s): Wynn Tom, Taylor Sarah, Zander Clark
Mar/Apr 2021 Pg. 163-168	Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes Author(s): Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
Mar/Apr 2021 Pg. 169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
May/Jun 2021 Pg. 180	PreScription: The Ethical Pharmacist Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 182-186	Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding Author(s): Zamani Mazdak, Chan Kayin, Wilcox Julie
May/Jun 2021 Pg. 190-195	Insurance Considerations for the Pharmacy Professional Author(s): Jones Kirsten
May/Jun 2021 Pg. 197-204	A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies Author(s): Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
May/Jun 2021 Pg. 206-209	FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Author(s): Brunner Scott
May/Jun 2021 Pg. 211-216	Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding Author(s): Mulder Kyle
May/Jun 2021 Pg. 218-221	Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 230-231	Calculations Author(s): Stockton Shelly J
May/Jun 2021 Pg. 232	Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 233	Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 235	Temozolomide 10 mg/mL in Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 236-240	Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Author(s): Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021 Pg. 241-245	In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester Author(s): McKinney Rachael D, Dunbar Jacob R
May/Jun 2021 Pg. 246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Author(s): Hui Ada, Yin Jian, Liu Wei, Zheng Kai
May/Jun 2021 Pg. 258-262	Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation Author(s): Odanaka Keita, Kojima Hiroki, Nakagawa Naoto
Jul/Aug 2021 Pg. 268	PreScription: Endemics, Epidemics, and Pandemics Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 270-274	Growing a Compounding Practice: Successful Marketing to Underserved Populations Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2021 Pg. 276-281	Expecting the Expected: Planning Considerations for Cleanroom Construction Author(s): Roberts Patricia A, Kroon Laura
Jul/Aug 2021 Pg. 282-287	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2 Author(s): Riepl Mike
Jul/Aug 2021 Pg. 288-295	Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Jul/Aug 2021 Pg. 296-297	A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Author(s): Brunner Scott
Jul/Aug 2021 Pg. 298-302	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 318	Calculations Author(s): Stockton Shelly J
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 324	Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 329	Valsartan 4-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 330-335	Stability of Dexmedetomidine in Polyvinyl Chloride Bags Containing 0.9% Sodium Chloride Intended for Subcutaneous Infusions Author(s): Wolfe Amanda, Zhang Jeremy, Lapenskie Julie, Downar James, Kanji Salmaan
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021 Pg. 344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Sep/Oct 2021 Pg. 356	PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Sep/Oct 2021 Pg. 378-384	Realities of Pharmaceutical Compounding in the Republic of Uzbekistan Author(s): Umarov Ulugbek, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar
Sep/Oct 2021 Pg. 386-387	It's Time for a New Philosophy Author(s): Brunner Scott
Sep/Oct 2021 Pg. 389-395	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 403-408	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 410	Calculations Author(s): Stockton Shelly J
Sep/Oct 2021 Pg. 412	Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 413	Cilazapril 1-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 415	Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 417	Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 418	Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 419	Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 421	Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 422-426	Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Author(s): Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
Sep/Oct 2021 Pg. 427-430	Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base Author(s): Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Sep/Oct 2021 Pg. 431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Nov/Dec 2021 Pg. 444	PreScription: IJPC -- Twenty-Five Year Anniversary Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 446-462	Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Author(s): Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021 Pg. 464-467	Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports Author(s): Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana
Nov/Dec 2021 Pg. 468-472	Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin Author(s): Riepl Mike
Nov/Dec 2021 Pg. 475-481	Hospital Compounding in Nigeria: A Review of Needs, Practice, and Suggestions for Pharmaceutical Dispensing Ciurriculum Development Author(s): Orubu Ebiowei Samuel F, Patani Bernard Opatimidi, Arhewoh Matthew Ikhuoria
Nov/Dec 2021 Pg. 482-485	Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars Author(s): Harris Kylie, Wright Edward
Nov/Dec 2021 Pg. 486-489	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents) Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 498	Calculations Author(s): Stockton Shelly J
Nov/Dec 2021 Pg. 500	Domperidone 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 501	Kayexalate in Lactulose Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 502	Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 503	Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 504	Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 505	Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 507	Shari's Burn Cream Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 508	Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 510-514	Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020 Author(s): Hecq Jean-Daniel, Soumoy Laura
Nov/Dec 2021 Pg. 515-522	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021 Pg. 523-527	Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution Author(s): Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim